Skip to main content

Table 1 Mouse Lung: Significantly differentially expressing genes

From: Induction of the interleukin 6/ signal transducer and activator of transcription pathway in the lungs of mice sub-chronically exposed to mainstream tobacco smoke

Description

*Fold change

Xenobiotic Metabolism

1

2

3

4

Cytochrome P450, family 1(Cyp1a1)

24.20

-1.02

26.93

-1.11

Cytochrome P450, family 1(Cyp1b1)

7.26

1.05

7.79

1.05

Aryl-hydrocarbon receptor repressor (Ahrr)

2.46

-1.04

3.92

1.13

NAD(P)H dehydrogenase, quinone 1 (Nqo1)

2.64

1.06

3.70

-1.00

Redox Balance

    

Carbonyl reductase 3 (Cbr3)

3.42

1.11

3.54

-1.03

homolog (S. cerevisiae) (Srxn1)

1.93

1.04

3.23

-1.06

Alcohol dehydrogenase 7 (class IV)(Adh7)

2.15

-1.02

3.22

1.08

Aldehyde dehydrogenase family 3, subfamily A1 (Aldh3a1)

3.08

1.09

3.08

1.07

Aldo-keto reductase family 1

2.03

1.03

2.34

1.09

Thioredoxin reductase 1 (Txnrd1)

2.06

1.03

2.32

1.05

Aldehyde oxidase 1 (Aox1)

1.24

1.08

2.23

1.16

Glutathione metabolism

    

Glutamate-cysteine ligase, catalytic subunit (Gclc)

2.40

1.00

4.06

1.30

Glutamate-cysteine ligase, modifier subunit (Gclm)

1.87

1.00

2.14

-1.04

Glutathione reductase 1 (Gsr)

1.31

1.06

1.34

-1.00

Glutathione S-transferase, theta 2 (Gstt2)

-1.38

1.08

-1.05

1.12

Oxidative stress, Inflammatory pathways

    

Heme oxygenase (decycling) 1 (Hmox1)

2.32

-1.09

4.41

-1.08

Interleukin 6 (Il6)

1.06

1.38

2.48

1.12

Prostaglandin-endoperoxide synthase 2 (Ptgs2)

1.87

1.47

2.91

1.13

Suppressor of cytokine signaling 3 (Socs3)

1.41

1.16

1.70

1.05

Lectin, galactose binding, soluble 3 (Lgals3)

1.55

-1.09

1.53

-1.11

Tumor necrosis factor, alpha-induced protein 2 (Tnfaip2)

1.53

1.16

1.30

-1.05

Paraoxonase 3 (Pon3)

1.31

1.01

1.43

1.14

Molecular chaperones

    

Heat shock protein 1A (Hspa1a)

2.37

-1.22

2.69

-1.46

Heat shock 70 kDa protein 4 like (Hspa4l)

1.52

-1.01

1.79

-1.03

Development

    

keratin complex 1, acidic, gene 19 (Krt1-19)

1.60

1.05

1.68

-1.02

ADP-ribosylation factor related protein 2 (Arfrp2)

-1.60

-1.02

-1.40

-1.08

Procollagen, type V, alpha 1 (Col5a1)

-1.24

1.07

-1.38

-1.01

Signal transduction pathways

    

Mitogen-activated protein kinase kinase kinase 6 (Map3k6)

1.44

-1.12

1.79

-1.17

PH domain and leucine rich repeat protein phosphatase

1.64

-1.03

1.12

-1.04

Breast cancer anti-estrogen resistance 3 (Bcar3)

1.30

-1.10

1.56

-1.02

Inosine triphosphatase (nucleoside triphosphate pyrophosphatase) (Itpa)

1.22

1.08

1.06

1.01

Cytoplasmic tyrosine kinase, Dscr28C related (Drosophila) (Tec)

-1.25

-1.03

1.04

1.08

Serine/threonine kinase 4 (Stk4)

1.47

1.01

-1.04

-1.17

Immediate early response 3 (Ier3)

1.42

1.03

1.47

-1.23

Sphingosine kinase 1 (Sphk1)

1.23

-1.24

1.51

-1.26

Platelet derived growth factor receptor, beta polypeptide (Pdgfrb)

-1.42

1.02

-1.50

1.07

Transport

    

Chloride channel 2 (Clcn2)

-1.39

1.05

-1.07

1.06

Solute carrier family 12, member 1 (Slc12a1)

-1.57

1.02

-1.04

1.26

Transcription

    

Nuclear antigen Sp100 (Sp100)

-1.55

1.11

-1.32

1.00

Chromatin accessibility complex 1 (Chrac1)

1.47

1.07

1.03

-1.11

X-box binding protein 1 (Xbp1)

1.36

-1.14

1.18

-1.10

TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated

1.29

1.07

1.30

1.04

Transcription factor E2a (Tcfe2a)

-1.29

-1.02

-1.35

-1.08

Structure

    

LIM-domain containing, protein kinase (Limk1)

1.49

1.06

1.30

-1.14

DIX domain containing 1 (Dixdc1)

-1.31

1.20

-1.41

1.16

Ankyrin 3, epithelial (Ank3), transcript variant 1

-1.14

1.09

-1.27

1.10

Oncogene, tumour suppressor

    

B-cell leukemia/lymphoma 3 (Bcl3)

1.73

1.00

2.13

-1.15

T-cell lymphoma invasion and metastasis 1 (Tiam1)

-1.19

1.13

-1.45

1.10

Kruppel-like factor 9 (Klf9)

1.02

-1.47

1.01

-1.32

Others

    

Growth arrest and DNA-damage-inducible 45 gamma (Gadd45g)

1.21

-1.01

1.95

-1.18

Enoyl Coenzyme A hydratase domain containing 3 (Echdc3)

-1.50

1.13

-1.12

1.13

Cathepsin D (Ctsd)

1.54

-1.05

1.46

1.03

Angiomotin like 2 (Amotl2)

1.47

1.15

-1.02

-1.02

Glucose-6-phosphate dehydrogenase X-linked (G6pdx)

1.42

-1.00

1.20

-1.05

TG interacting factor (Tgif)

-1.06

1.07

1.33

-1.01

Nucleolar protein 5A (Nol5a)

1.31

1.02

1.03

-1.10

Protein-O-mannosyltransferase 1 (Pomt1)

-1.24

1.02

-1.03

1.05

Chitinase 3-like 3 (Chi3l3)

3.19

-1.12

2.91

1.25

Leukotriene C4 synthase (Ltc4s)

1.81

-1.06

1.19

1.10

ATPase, H+ transporting, V0 subunit D, isoform 2 (Atp6v0d2)

1.76

-1.15

1.58

-1.13

Cold inducible RNA binding protein (Cirbp)

-1.48

1.14

-1.58

1.06

Unknown and RIKENS

    

Lung-inducible neuralized-related C3HC4 RING domain protein (Lincr)

1.45

1.08

1.22

-1.04

Selenocysteine lyase (Scly)

-1.29

1.14

-1.26

1.00

RIKEN cDNA B230118H07 gene

-1.07

1.08

-1.29

1.12

RIKEN cDNA 1110019L22 gene

1.13

1.02

-1.22

-1.27

Zinc finger CCCH type, antiviral 1 (Zc3hav1)

-1.33

-1.06

-1.18

-1.02

RIKEN cDNA 9830165K03

-1.40

1.12

-1.18

1.02

RIKEN cDNA 2310007H09 gene

-1.38

1.11

-1.07

1.11

mRNA for mKIAA1201 protein

-1.31

1.09

-1.36

1.00

Oolfactory receptor 1286 (Olfr1286)

-1.87

1.17

1.06

-1.04

Procollagen, type III, alpha 1 (Col3a1)

-1.59

-1.05

-1.77

1.17

RIKEN cDNA 1190002H23 gene

-1.25

-1.14

1.73

-1.06

4 days neonate male adipose cDNA, RIKEN

1.23

-1.54

1.15

-1.70

Roundabout homolog 2 (Drosophila) (Robo2)

-1.66

1.04

-1.18

1.22

Adult male urinary bladder cDNA, RIKEN

1.11

1.12

-1.04

-1.64

RIKEN cDNA 1700012B18 gene

1.33

-1.23

2.25

-1.21

Btg3 associated nuclear protein (Banp)

-1.36

-1.48

1.16

1.06

RIKEN cDNA 9130213B05 gene

1.39

1.00

1.52

-1.01

E74-like factor 3 (Elf3)

1.51

1.03

1.47

1.06

  1. * 1. 6 weeks smoke, 2. 6 weeks smoke followed by 6 weeks break, 3. 12 weeks smoke
  2. 4. 12 weeks smoke followed by 6 weeks break